Abeona Therapeutics Inc.

ABEONASDAQHealthcare● Active

$5.43

$-0.04(-0.64%)

Market Cap$309198656

P/E Ratio—

52W High$7.54

52W Low$4

Avg Volume1.2M

Open$5.51

Beta1.35

Overview

Stock ranking:Biotechnology·Healthcare·View All Market Cap Rankings →

Abeona Therapeutics Inc. (ABEO) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ABEO · as of Jun 8, 2026

Key Statistics

EPS (TTM)$1.28Earnings history

PE Ratio (TTM)4.2×PE Ratio deep dive

Revenue (TTM)$14.5MFull revenue history

Dividend Yield8.55%Dividend history

Shares Outstanding53.0MShares outstanding history

Next EarningsAug 13, 2026Est.Earnings history

Explore Abeona Therapeutics Inc. Data

Market Cap$308.6M

Analyst Forecast$17 · Buy

Dividends8.55%

Revenue$5.8M

EarningsEPS $1.34+186.45%

PE Ratio4.2×

Financial Snapshot

Full Financials

FY 2025Revenue$5.8M

202320242025

FY 2025Net Income$71.2M▲ +211.69% YoY

202320242025

FY 2025EPS$1.34▲ +186.45% YoY

202320242025

TTM:Revenue: $14.5MNet Income: $66.1MEPS: $1.28View income statement →

Analyst Ratings & Price Target

Full Forecast

Buy9 analysts

Strong Buy

Buy

Hold

Sell

Strong Sell

12-Month Price Target

$17.00Low

$5.42Current

$17.00Avg Target213.36% upside

$17.00High

Total: 9 · Buy rate: 66.7%

The ABEO analyst consensus is Buy, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $17.00, representing +213.36% upside from the current price of $5.42.

Competitors & Peers

#TickerCompanyPriceChangeMkt Cap

ABEO

Abeona Therapeutics Inc.

$5.43-0.64%$309.2M #2

ARCT

Arcturus Therapeutics Holdings Inc.

$7.20-1.44%$204.5M #3

ASMB

Assembly Biosciences, Inc.

$22.30-0.96%$354.4M #4

ELDN

Eledon Pharmaceuticals, Inc.

$3.55+3.96%$212.5M #5

FHTX

Foghorn Therapeutics Inc.

$3.64-2.68%$213.7M #6

HUMA

Humacyte, Inc.

$1.41+4.07%$236.0M

Stock Performance

Full History

1D-0.82%

1W-4.50%

1M-8.22%

3M+11.65%

YTD+2.75%

1Y-17.20%

5Y-87.90%

About Abeona Therapeutics Inc.

CEOVishwas Seshadri

IPO DateSep 19, 1980

Employees136

CountryUS

Websiteabeonatherapeutics.com

Abeona Therapeutics Inc. a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corre…

Biotechnology HealthcareNASDAQUS

About Stock Overview & Key Data

Abeona Therapeutics Inc. (ABEO) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Sep 19, 1980. As of the latest trading session, ABEO stock price is $5.42, with a market capitalization of $308.6M. The stock has returned -17.20% over the past 12 months and +2.75% year-to-date.

According to 9 Wall Street analysts, the consensus rating for Abeona Therapeutics Inc. stock is Buy, with an average 12-month price target of $17.00. In fiscal year 2025, Abeona Therapeutics Inc. reported revenue of $5.8M and net income of $71.2M. For detailed data — including Abeona Therapeutics Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Abeona Therapeutics Inc. (ABEO) stock price is $5.42. The stock is traded on NASDAQ under the ticker symbol ABEO. The 52-week range is $4.00 – $7.54.

ABEO stock priceABEO quote todaylive ticker

Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice